Somatic Opsins for Single Cell Resolution Optogenetics
Non-Exclusively Licensed
Invention type: Technology, Tangible Property
/
Case number: #18756TE
The invention, in some aspects, relates to polypeptide molecules and their encoding nucleic acid molecules and use of such molecules to target opsins to the soma of cells in which they are expressed. Compositions of the invention may be delivered to cells and subjects and used in methods to modulate electrical activity of cells in which they are expressed, and for treatment of diseases and conditions in subjects.
Researchers
Edward Stuart Boyden
/
Changyang Linghu
/
Or Shemesh
Departments: Department of Brain and Cognitive Sciences
Technology Areas: Biotechnology: Biomedical Devices & Systems, Sensors & Monitoring, Synthetic Biology / Diagnostics: Assays / Drug Discovery and Research Tools: Cell Interrogation / Sensing & Imaging: Optical Sensing
Impact Areas: Healthy Living
-
somatic opsins for single cell resolution optogenetics
United States of America | Granted | 11,324,824
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.